Page last updated: 2024-10-27

fluconazole and Cardiac Hypertrophy

fluconazole has been researched along with Cardiac Hypertrophy in 2 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Shoieb, SM2
Alammari, AH2
Levasseur, J1
Silver, H1
Dyck, JRB1
El-Kadi, AOS2
Maayah, ZH1

Other Studies

2 other studies available for fluconazole and Cardiac Hypertrophy

ArticleYear
Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats.
    Journal of cardiovascular pharmacology, 2022, 06-01, Volume: 79, Issue:6

    Topics: Animals; Cardiomegaly; Constriction; Fluconazole; Hydroxyeicosatetraenoic Acids; Hypertrophy, Left V

2022
Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
    Journal of pharmaceutical sciences, 2020, Volume: 109, Issue:7

    Topics: Angiotensin II; Animals; Arachidonic Acid; Cardiomegaly; Cytochrome P-450 Enzyme System; Fluconazole

2020